サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1574984

慢性疾患管理市場：プラットフォームタイプ別、サービスタイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Chronic Disease Management Market, By Platform Type, By Service Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
慢性疾患管理市場：プラットフォームタイプ別、サービスタイプ別、疾患タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

慢性疾患管理市場規模は2023年に51億932万米ドルとなり、2024年から2032年にかけてCAGR 14.90%で拡大

慢性疾患管理市場- 市場力学

予防ヘルスケア重視の高まりが慢性疾患管理市場の拡大を後押し

予防ヘルスケアを重視する傾向が強まっており、早期介入と継続的ケアの重要性を認識する組織や政府が増えているため、慢性疾患管理市場の拡大を大きく後押ししています。米国疾病予防管理センター（CDC）によると、慢性疾患は米国における10大死因のうち7つを占めており、効果的な管理戦略の緊急性が浮き彫りになっています。米国国立衛生研究所（National Institute of Health）の研究によると、生活習慣の改善と予防対策により、慢性疾患の発症リスクを80％低減できる可能性があるといいます。さらに、世界保健機関（WHO）の世界行動計画（Global Action Plan）のようなイニシアチブは、2025年までに非伝染性疾患による早期死亡率を25%削減することを目標としており、予防に焦点を当てた包括的な慢性疾患管理プログラムの必要性を強化しています。

慢性疾患管理市場-主な洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約14.90%のCAGRで毎年成長すると推定されます。

プラットフォームタイプ別では、クラウドベースのソリューションが2023年に最大の市場シェアを示すと予測されています。

サービスタイプ別では、ケアコーディネーションが2023年の主要タイプです。

疾患タイプ別では、2023年には心血管疾患が主要タイプに

地域別では、北米が2023年に収益を生み出す主要市場となっています。

慢性疾患管理市場-セグメンテーション分析：

世界の慢性疾患管理市場は、プラットフォームタイプ、サービスタイプ、疾患タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場はプラットフォームタイプ別では、3つのカテゴリーに分けられる：ウェブベース・ソリューション、クラウドベース・ソリューション、オンプレミス・ソリューションです。クラウドベースのソリューションは、そのスケーラビリティとアクセシビリティにより人気が高く、患者や医療提供者にとって使いやすいインターフェースを提供するウェブベースのソリューションがこれに続く。オンプレミス・ソリューションは、主にデータ・セキュリティのために大規模ヘルスケア機関で使用されており、第3位にランクされています。

市場はサービスタイプ別で、4つのカテゴリーに分けられる：コンサルティング、ケアコーディネーション、教育＆トレーニング、監視と評価です。ケアコーディネーションサービスは、患者管理における重要な役割として優先され、次いで継続的な評価を保証する監視と評価サービスが続く。コンサルティングは第3位で、教育・トレーニングサービスは患者の能力向上に不可欠です。

慢性疾患管理市場-地理的洞察

慢性疾患管理市場は多様な地域力学を示し、中でも北米は高いヘルスケア支出と高度なインフラが牽引役となっています。米国では、CDCの全国糖尿病予防プログラムのような取り組みにより、参加者の糖尿病発症率を58%減少させることに成功しています。100万人以上の患者の転帰改善を目指すNHSの糖尿病管理プログラムに見られるように、ドイツや英国のような国では、慢性疾患を効果的に管理するための統合ケアモデルを優先しています。アジア太平洋地域は、意識の高まりと高齢者人口の増加に後押しされ、急速に台頭しています。例えば、日本の厚生省は、慢性疾患と闘うため、肥満とメタボリックシンドロームを対象とした独自の健康管理イニシアチブを実施しています。ラテンアメリカでは、ブラジルがより予防的なヘルスケア・モデルを目指し、高血圧や糖尿病に対処するための公衆衛生キャンペーンに力を入れています。最後に、中東とアフリカでは、ヘルスケア技術への投資が増加しており、遠隔医療サービスや地域医療プログラムを通じて慢性疾患管理を強化することを目指した取り組みが行われています。

慢性疾患管理市場-競合情勢：

慢性疾患管理市場の競合情勢は、さまざまな地域の主要企業によって形成されており、それぞれが患者ケアの強化に積極的に取り組んでいます。北米は依然としてリーダー的存在で、UnitedHealth GroupやCignaなどの企業が慢性疾患管理を合理化するための革新的なデジタルヘルスプラットフォームに投資しています。CMS Chronic Care Managementプログラムのようなイニシアチブは、ケア協調を改善するために30万人以上のメディケア受給者の登録に成功しています。欧州では、バイエルやサノフィのような大手企業が包括的なケアモデルに注力しており、2025年までに慢性疾患の有病率を20%削減することを目的としたEUの保健イニシアティブに支えられています。アジア太平洋地域は急成長を遂げており、フィリップスのような組織が遠隔医療サービスを開始し、オーストラリアなどの国々ではパンデミック時に利用が140%増加しました。ラテンアメリカも台頭してきており、ブラジルの"Saude na Hora "のようなイニシアチブは、十分なサービスを受けていない地域社会全体に利用しやすい慢性疾患管理サービスを提供することを目的としています。一方、中東とアフリカでは、シーメンス・ヘルティニアーズのような企業に牽引され、ヘルスケア・テクノロジーへの投資が増加しています。

目次

第1章 慢性疾患管理市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 慢性疾患管理の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 慢性疾患管理産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 慢性疾患管理市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 慢性疾患管理市場情勢

  • 慢性疾患管理市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 慢性疾患管理市場- プラットフォームタイプ別

  • 概要
    • プラットフォームタイプ別セグメントシェア分析
    • Webベースのソリューション
    • クラウドベースのソリューション
    • オンプレミスソリューション

第8章 慢性疾患管理市場- サービスタイプ別

  • 概要
    • サービスタイプ別セグメントシェア分析
    • コンサルティング
    • ケアコーディネーション
    • 教育とトレーニング
    • 監視と評価

第9章 慢性疾患管理市場- 疾患タイプ別

  • 概要
    • 疾病タイプ別セグメントシェア分析
    • 糖尿病
    • 心血管疾患
    • 呼吸器疾患
    • がん
    • その他

第10章 慢性疾患管理市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院・クリニック
    • ホームケア
    • 診断センター
    • 支払者

第11章 慢性疾患管理市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 慢性疾患管理業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Allscripts Healthcare Solutions, Inc.
    • Altruista Health, Inc.
    • Cerner Corporation
    • Cognizant Technology Solutions Corporation
    • Epic Systems Corporation
    • GE Healthcare
    • Health Catalyst, Inc.
    • i2i Population Health
    • IBM Corporation
    • Infosys Limited
    • Koninklijke Philips NV
    • McKesson Corporation
    • Medtronic plc
    • Pegasystems Inc.
    • Siemens Healthineers AG
    • ZeOmega, Inc.
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV3993

REPORT HIGHLIGHT

Chronic Disease Management Market size was valued at USD 5,109.32 Million in 2023, expanding at a CAGR of 14.90% from 2024 to 2032.

The Chronic Disease Management Market encompasses various strategies and technologies designed to improve health outcomes for individuals with chronic conditions. Chronic disease management involves the ongoing care and support of patients with long-term illnesses like diabetes, hypertension, and heart disease, with approximately 60% of adults in the U.S. living with at least one chronic condition. Rising healthcare costs, an aging population, and increasing awareness about preventive healthcare are significant factors propelling the demand for chronic disease management solutions. However, challenges such as high implementation costs, lack of skilled professionals, and patient non-compliance can hinder market growth. On the flip side, opportunities abound in the form of advancements in telemedicine, the growing integration of artificial intelligence in healthcare, and the increasing focus on personalized medicine, which can enhance the effectiveness of chronic disease management programs and improve patient adherence.

Chronic Disease Management Market- Market Dynamics

Growing Emphasis on Preventive Healthcare Fuels Expansion of the Chronic Disease Management Market

The growing emphasis on preventive healthcare is significantly driving the expansion of the Chronic Disease Management Market, as organizations and governments increasingly recognize the importance of early intervention and ongoing care. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 7 of the 10 leading causes of death in the United States, highlighting the urgent need for effective management strategies. A study by the National Institute of Health found that lifestyle changes and preventive measures could reduce the risk of developing chronic diseases by 80%. Furthermore, initiatives like the World Health Organization's Global Action Plan aim to reduce premature mortality from non-communicable diseases by 25% by 2025, reinforcing the necessity for comprehensive chronic disease management programs that focus on prevention.

Chronic Disease Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.90% over the forecast period (2024-2032)

Based on Platform Type segmentation, Cloud-based solutions was predicted to show maximum market share in the year 2023

Based on Service Type segmentation, Care coordination was the leading type in 2023

Based on Disease Type segmentation, cardiovascular diseases was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Chronic Disease Management Market- Segmentation Analysis:

The Global Chronic Disease Management Market is segmented on the basis of Platform Type, Service Type, Disease Type, End-User, and Region.

The market is divided into three categories based on Platform Type: Web-Based Solutions, Cloud-Based Solutions, and On-Premise Solutions. Cloud-based solutions lead in popularity due to their scalability and accessibility, followed by web-based solutions that offer user-friendly interfaces for patients and providers. On-premise solutions rank third, primarily used by large healthcare organizations for data security.

The market is divided into Four categories based on Service Type: Consulting, Care Coordination, Education & Training, and Monitoring & Assessment. Care coordination services are prioritized for their critical role in patient management, followed by monitoring and assessment services that ensure ongoing evaluation. Consulting ranks third, while education and training services are essential for empowering patients.

Chronic Disease Management Market- Geographical Insights

The Chronic Disease Management Market exhibits diverse geographical dynamics, with North America leading the charge, driven by high healthcare expenditure and advanced infrastructure. In the U.S., initiatives like the CDC's National Diabetes Prevention Program have successfully reduced diabetes incidence among participants by 58%. Europe follows closely, where countries like Germany and the UK are prioritizing integrated care models to manage chronic diseases effectively, as evidenced by the NHS's commitment to diabetes management programs, which aim to improve outcomes for over 1 million patients. The Asia-Pacific region is rapidly emerging, fueled by rising awareness and a growing elderly population; for instance, Japan's health ministry has implemented a unique health management initiative targeting obesity and metabolic syndrome to combat chronic diseases. In Latin America, Brazil is working towards a more preventive healthcare model, focusing on public health campaigns to address hypertension and diabetes. Lastly, the Middle East and Africa are seeing increasing investment in healthcare technology, with initiatives aimed at enhancing chronic disease management through telehealth services and community health programs.

Chronic Disease Management Market- Competitive Landscape:

The competitive landscape of the Chronic Disease Management Market is shaped by key players across various regions, each actively working to enhance patient care. North America remains a leader, with companies like UnitedHealth Group and Cigna investing in innovative digital health platforms to streamline chronic disease management; initiatives such as the CMS Chronic Care Management program have successfully enrolled over 300,000 Medicare beneficiaries to improve care coordination. In Europe, major players like Bayer and Sanofi focus on comprehensive care models, supported by EU health initiatives aimed at reducing chronic disease prevalence by 20% by 2025. The Asia-Pacific region is witnessing rapid growth, with organizations like Philips launching telehealth services that increased by 140% in usage during the pandemic in countries like Australia. Latin America is also emerging, with initiatives such as Brazil's "Saude na Hora," which aims to provide accessible chronic disease management services across underserved communities. Meanwhile, the Middle East and Africa see increasing investments in healthcare technology, driven by firms like Siemens Healthineers, enhancing access to care and improving management strategies in the region.

Recent Developments:

In January 2024, Amazon launched a chronic condition management program in partnership with Omada Health, connecting users to services for diabetes and weight management. The initiative aims to help consumers access eligible benefits through Amazon's platform, enhancing healthcare accessibility

In February 2022, Teladoc Health launched its Chronic Care Complete program, targeting diabetes, prediabetes, and hypertension management. The initiative includes connected devices, personal health coaches, and mental health support, available through health plans or employers to enhance patient care and management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Allscripts Healthcare Solutions, Inc.
  • Altruista Health, Inc.
  • Cerner Corporation
  • Cognizant Technology Solutions Corporation
  • Epic Systems Corporation
  • GE Healthcare
  • Health Catalyst, Inc.
  • i2i Population Health
  • IBM Corporation
  • Infosys Limited
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Medtronic plc
  • Pegasystems Inc.
  • Siemens Healthineers AG
  • ZeOmega, Inc.
  • Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY PLATFORM TYPE- MARKET ANALYSIS, 2019 - 2032

  • Web-Based Solutions
  • Cloud-Based Solutions
  • On-Premise Solutions

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Consulting
  • Care Coordination
  • Education & Training
  • Monitoring & Assessment

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Diabetes
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Cancer
  • Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Centers
  • Payers

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chronic Disease Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chronic Disease Management Market Snippet by Platform Type
    • 2.1.2. Chronic Disease Management Market Snippet by Service Type
    • 2.1.3. Chronic Disease Management Market Snippet by Disease Type
    • 2.1.4. Chronic Disease Management Market Snippet by End-User
    • 2.1.5. Chronic Disease Management Market Snippet by Country
    • 2.1.6. Chronic Disease Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Chronic Disease Management Key Market Trends

  • 3.1. Chronic Disease Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chronic Disease Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chronic Disease Management Market Opportunities
  • 3.4. Chronic Disease Management Market Future Trends

4. Chronic Disease Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chronic Disease Management Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Chronic Disease Management Market Landscape

  • 6.1. Chronic Disease Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chronic Disease Management Market - By Platform Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Platform Type, 2023 & 2032 (%)
    • 7.1.2. Web-Based Solutions
    • 7.1.3. Cloud-Based Solutions
    • 7.1.4. On-Premise Solutions

8. Chronic Disease Management Market - By Service Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 8.1.2. Consulting
    • 8.1.3. Care Coordination
    • 8.1.4. Education & Training
    • 8.1.5. Monitoring & Assessment

9. Chronic Disease Management Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 9.1.2. Diabetes
    • 9.1.3. Cardiovascular Diseases
    • 9.1.4. Respiratory Diseases
    • 9.1.5. Cancer
    • 9.1.6. Others

10. Chronic Disease Management Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Homecare
    • 10.1.4. Diagnostic Centers
    • 10.1.5. Payers

11. Chronic Disease Management Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Chronic Disease Management Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Chronic Disease Management Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Chronic Disease Management Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Chronic Disease Management Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Chronic Disease Management Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Chronic Disease Management Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Allscripts Healthcare Solutions, Inc.
    • 12.2.2. Altruista Health, Inc.
    • 12.2.3. Cerner Corporation
    • 12.2.4. Cognizant Technology Solutions Corporation
    • 12.2.5. Epic Systems Corporation
    • 12.2.6. GE Healthcare
    • 12.2.7. Health Catalyst, Inc.
    • 12.2.8. i2i Population Health
    • 12.2.9. IBM Corporation
    • 12.2.10. Infosys Limited
    • 12.2.11. Koninklijke Philips N.V.
    • 12.2.12. McKesson Corporation
    • 12.2.13. Medtronic plc
    • 12.2.14. Pegasystems Inc.
    • 12.2.15. Siemens Healthineers AG
    • 12.2.16. ZeOmega, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us